• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device next generation sequencing oncology panel, somatic or germline variant detection system
Definition A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.
Product CodePQP
Device Class 3

Premarket Approvals (PMA)
2017 2018 2019 2020 2021 2022
6 15 21 25 16 30

MDR Year MDR Reports MDR Events
2017 1 1
2018 1 1
2020 1 1
2021 1 1
2022 1 1

Device Problems MDRs with this Device Problem Events in those MDRs
False Negative Result 1 1
Inadequate Instructions for Healthcare Professional 1 1
Off-Label Use 1 1
Product Quality Problem 1 1
Incorrect, Inadequate or Imprecise Result or Readings 1 1
Unexpected Therapeutic Results 1 1
Incorrect Or Inadequate Test Results 1 1
Ambient Temperature Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Patient Involvement 2 2
No Clinical Signs, Symptoms or Conditions 2 2
No Known Impact Or Consequence To Patient 1 1

Recalls
Manufacturer Recall Class Date Posted
1 Foundation Medicine, Inc. II Nov-22-2019
2 Foundation Medicine, Inc. II Dec-20-2018
3 Life Technologies Corporation II Apr-14-2020
4 Life Technologies Corporation II Apr-20-2018
5 Life Technologies Corporation II Mar-30-2018
-
-